Drug recall · March 5, 2014
Clonazepam Tablets recall
Why: Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton)
- Lots / codes
lot 58468552 Exp. 05/15
- Quantity
- 13,608 bottles
- Company
- Actavis Elizabeth LLC, Elizabeth, NJ
- Distribution
- Nationwide
- Initiated
- November 6, 2013 · Voluntary: Firm initiated
- Classified
- February 21, 2014
- Reported
- March 5, 2014
- Ended
- June 2, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.